OrderlyMeds, a fully online weight loss platform, has updated its treatment programs and is now offering options for compounded tirzepatide.
-- Overweight or obese individuals looking to lose weight to manage health conditions like high blood pressure, diabetes, sleep apnea, high cholesterol, or cardiovascular disease can contact OrderlyMeds to determine eligibility for its newly announced medically supervised weight loss programs, which have been updated to include compounded GLP-1/GIP medications like tirzepatide.
For more information, please visit https://orderlymeds.com/treatments/glp1s/compounded-glp1-gip/
Compounded medications use active ingredients in FDA-approved drugs for custom formulations designed to provide the same effect as brand-name products. For weight loss programs, tirzepatide, a GLP-1 and GIP agonist and the primary ingredient in Mounjaro and Zepbound, is often compounded to create a more affordable alternative to brand-name drugs, which patients may find inaccessible due to higher costs or shortages.
OrderlyMeds offers compounded tirzepatide as part of its online weight loss programs, providing patients with injections with personalized formulations based on their health goals and medical history. These custom medications are compounded in licensed compounding pharmacies, ensuring they are safe for use and have the same appetite-reducing effect as their brand-name counterparts. Additionally, they may include supplements such as vitamin B6 and B12 for added efficacy, but individual formulas may differ depending on the patient’s needs.
To be eligible for OrderlyMeds’ treatments, patients must be 18 years or older and have a BMI greater than 27, and they cannot be pregnant or have medical conditions such as hyperthyroidism, gastroparesis, pancreatitis, inflammatory bowel disease, or certain cancers. Eligibility for the program will be determined by one of OrderlyMeds’ licensed physicians, who will prescribe either compounded GLP-1/GIP or other medications deemed medically appropriate for the client.
For individuals new to GLP-1 medications, OrderlyMeds offers a starter program that includes 12 weekly doses, starting at 2.5 mg for the first four weeks and increasing in 2.5 mg increments to help the body adjust to the medication. Patients transferring from a different GLP-1 program will instead have 12 weekly doses at the same strength, with up to 15 mg available.
Regardless of the program, medications will be shipped directly to the client’s address. Additionally, follow-up appointments will be carried out online, allowing the patient to receive treatment from the comfort of their home.
Interested parties can learn more by visiting https://orderlymeds.com/
Contact Info:
Name: Annie Dawson
Email: Send Email
Organization: OrderlyMeds
Address: 235 Ponce De Leon Pl Suite M347, Decatur, Georgia 30030, United States
Website: https://orderlymeds.com/
Source: PressCable
Release ID: 89183389
In case of encountering any inaccuracies, problems, or queries arising from the content shared in this press release that necessitate action, or if you require assistance with a press release takedown, we urge you to notify us at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be readily available to promptly address your concerns within 8 hours, resolving any identified issues diligently or guiding you through the necessary steps for removal. The provision of accurate and dependable information is our primary focus.
